OUR AIM IS TO SUPPORT AND GUIDE PATIENTS THROUGH THE DIAGNOSIS AND TREATMENT OF SKIN CANCER
We will work with the patient through the pathway ensuring that they feel cared for and informed throughout a potentially worrying and stressful time. We provide fast access to the finest specialists in the field, see the patient promptly and provide same day outpatient diagnostics if necessary.
When a diagnosis is confirmed, decision about the treatment plan is discussed with the patient and our specialist multi-disciplinary team, which may involve chemotherapy, radiotherapy and surgery.
- Mohs micrographic surgery
- Photodynamic Therapy (PDT)
- Chemotherapy creams/gels
Cancer conditions we treat
With our dedicated skin cancer specialist multi-disciplinary team we are able to treat a number of skin cancers.
- Malignant melanoma
- Non-melanoma skin cancer
- Basal cell carcinoma
- Squamos cell carcinoma
- Rare skin cancers
Our Multi-Disciplinary Team (MDT)
Our Multi-Disciplinary Teams (MDT) of specialists meet on a regular basis to discuss and carefully review individual cases and second opinions referred to them from all over the world. Having considered all the evidence, they independently provide the most appropriate treatment plan followed by a written report for each patient.
Medical opinion from an MDT provides referring doctors and patients with valued reassurance and peace of mind about the best way forward.
All of the various Clinicians are highly-rated experienced experts in the field of Skin cancer within both the NHS and private practice and belong to the expert Skin MDT, sharing and practicing cutting edge medicine.
HOW TO USE OUR SERVICE
If you wish to have a case reviewed by one of expert MDTs, or to make an enquiry, please email us at THSC.MDT@hcahealthcare.co.uk or telephone +44 (0)20 7034 8228.
Referrals for UK patients can either be made from a medical professional or a patient seeking a second opinion.
International patients can be referred to an MDT at The Harley Street Clinic without the need to fly to the UK.